Association between GRN rs5848 Polymorphism and Parkinson′s Disease in Taiwanese Population

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chang, Kuo Hsuan ^a   Chen, Chiung Mei ^a   Chen, Yi Chun ^a   Hsiao, Ya Chin ^b   Huang, Chin Chang ^a   Kuo, Hung Chou ^a   Hsu, Hsuan Chu ^b   Lee Chen, Guey Jen ^b   Wu, Yih Ru ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; THYMINE;

ADULT; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRN GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION RESEARCH; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWANESE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PARKINSON DISEASE; POLYMORPHISM, GENETIC; TAIWAN;

EID: 84872463000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054448     Document Type: Article

References (38)

1. Lang AE, Lozano AM, (1998) Parkinson's disease. First of two parts. N Engl J Med 339: 1044-1053.
2. Dauer W, Przedborski S, (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909.
3. Bhandari V, Bateman A, (1992) Structure and chromosomal location of the human granulin gene. Biochem Biophys Res Commun 188: 57-63.
4. Suzuki M, Lee HC, Kayasuga Y, Chiba S, Nedachi T, et al. (2009) Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis. J Reprod Dev 55: 351-355.
5. He Z, Bateman A, (1999) Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo. Cancer Res 59: 3222-3229.
6. He Z, Ong CH, Halper J, Bateman A, (2003) Progranulin is a mediator of the wound response. Nat Med 9: 225-229.
7. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, et al. (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17: 3631-3642.
8. Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, et al. (2009) GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease. Eur J Neurol 16: 909-911.
9. Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, et al. (2007) Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 13: 89-92.
10. Ross OA, Wu YR, Lee MC, Funayama M, Chen ML, et al. (2008) Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann Neurol 64: 88-92.
11. Tan EK, Peng R, Teo YY, Tan LC, Angeles D, et al. (2010) Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 31: 561-568.
12. Biskup S, Mueller JC, Sharma M, Lichtner P, Zimprich A, et al. (2005) Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Ann Neurol 58: 905-908.
13. Paisan-Ruiz C, Evans EW, Jain S, Xiromerisiou G, Gibbs JR, et al. (2006) Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet 43: e9.
14. Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 41: 1303-1307.
15. Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, et al. (2010) Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 75: 508-512.
16. Finch N, Baker M, Crook R, Swanson K, Kuntz K, et al. (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132: 583-591.
17. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G, (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71: 1235-1239.
18. Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, et al. (2009) Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol 65: 603-609.
19. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, et al. (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181: 37-41.
20. Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW, (2007) Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 4: 7.
21. Hsiung GY, Fok A, Feldman HH, Rademakers R, Mackenzie IR, (2011) rs5848 polymorphism and serum progranulin level. J Neurol Sci 300: 28-32.
22. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, et al. (2000) Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 55: 1358-1363.
23. Chen CC, Chen TF, Hwang YC, Wen YR, Chiu YH, et al. (2009) Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan. Neuroepidemiology 33: 350-357.
24. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, et al. (2008) Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70: 200-209.
25. Saunders-Pullman R, (2003) Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine 21: 81-87.
26. Gillies GE, McArthur S, (2010) Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens. Horm Behav 57: 23-34.
27. Simunovic F, Yi M, Wang Y, Stephens R, Sonntag KC, (2010) Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS One 5: e8856.
28. Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, et al. (2007) Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis 26: 606-614.
29. Spencer CC, Plagnol V, Strange A, Gardner M, Paisan-Ruiz C, et al. (2011) Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet 20: 345-353.
30. Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, et al. (2011) Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet 20: 615-627.
31. Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, et al. (2011) Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet 12: 104.
32. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, et al. (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 42: 781-785.
33. Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, et al. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 74: 97-109.
34. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, et al. (2009) Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41: 1308-1312.
35. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, et al. (2009) Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124: 593-605.
36. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, et al. (2006) Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 5: 911-916.
37. Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, et al. (2011) Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet 7: e1002237.
38. Hughes AJ, Daniel SE, Kilford L, Lees AJ, (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.